Now available in DASH: Researchers can request access to NICHD biospecimens for secondary analyses.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Media Advisory: NICHD chronicles its major research advances of 2018
As 2018 winds down, a new slideshow highlights a selection of initiatives, therapies, and scientific advances supported by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Spotlight: Selected NICHD Research Advances of 2018
In 2018, researchers funded by NICHD made significant progress in advancing the health and well-being of infants, children, teenagers, and adults across the United States and around the world.
Release: NIH funds study to prevent, treat HIV among adolescents in poor countries
The National Institutes of Health has awarded $7.5 million for an international research program to prevent and treat HIV infection among adolescents and young adults in seven African countries and Brazil.
Item of Interest: NIH extends study on HIV drug, dolutegravir, to evaluate potential safety concerns for pregnant women
The study seeks to determine if exposure poses a risk for neural tube defects.
Item of Interest: FDA approves PrEP therapy for adolescents at risk of HIV
The U.S. Food and Drug Administration (FDA) has approved an anti-HIV drug combination for use in at-risk adolescents. FDA’s decision was informed by an NICHD-supported study of adolescent males.
Drug combination reduces risk of HIV infection among teen males
A National Institutes of Health network study has confirmed that a combination of two drugs taken daily to reduce the chances of HIV infection among high-risk adults also works well and appears safe in males ages 15 to 17 years.
Release: Anti-HIV drug combination does not increase preterm birth risk, study suggests
A drug combination aimed at preventing transmission of HIV from a pregnant woman to her fetus likely does not increase the risk for preterm birth and early infant death, according to a re-analysis of two studies funded by the National Institutes of Health.
Item of Interest: NICHD reports success of data sharing resource, two years after launch
More than two years after its inception, NICHD’s Data and Specimen Hub (DASH) has received 73 data access requests and resulted in 3 published studies.
News Release: NIH Begins Large HIV Treatment Study in Pregnant Women
The National Institutes of Health has launched a large international study to compare the safety and efficacy of three antiretroviral treatment regimens for pregnant women living with HIV and the safety of these regimens for their infants.
Spotlight: Selected NICHD Research Advances of 2017
Over the past year, NICHD contributed to numerous scientific advances and key initiatives.
High doses of vitamin D3 may decrease bone loss associated with anti-HIV drug
A monthly high dose of vitamin D3 may prevent the loss of bone density often experienced by people taking the anti-HIV drug tenofovir disoproxil fumarate (TDF).
HIV hijacks surface molecule to invade cell
Researchers at the National Institutes of Health have discovered a key step in the process that HIV uses to inject its genetic material into cells.
Malaria drug protects fetal mice from Zika virus, NIH-funded study finds
Hydroxychloroquine, a drug approved by the Food and Drug Administration to treat malaria and certain autoimmune diseases in pregnant women, appears to reduce transmission of Zika virus from pregnant mice to their fetuses, according to a study funded in part by the National Institutes of Health.
NIH launches prospective study of Zika and HIV co-infection during pregnancy
The National Institutes of Health has launched a study to determine the potential risks that infection with the Zika virus might pose for pregnancies in which the mother is also infected with HIV.
Collaborative HIV program improves long-term care for youths in the United States
A pilot program to help teens and young adults with HIV navigate the health care system raised the percentage of youths who remained in care compared to national estimates, according to a study funded by NIH.
Cell particles may help spread HIV infection, NIH study suggests
HIV appears to enlist the aid of nano-sized structures released by infected cells to infect new cells, according to a study by researchers at NICHD.
NICHD scientists decipher how group of proteins regulate immune cell development in mice
Immune system proteins called Themis are essential for helping two major types of infection-fighting immune cells mature, according to two studies led by researchers at NICHD.
Selected NICHD Research Advances of 2016
NICHD had a very productive year in 2016. Staff responded quickly to Zika virus and led the effort to develop the NIH Research Plan on Rehabilitation. The following snapshots are examples of the many advances made possible by NICHD this year.
Getting to Know the New NICHD Director
NICHD Director Dr. Diana Bianchi shares some thoughts about joining NICHD.
BACK TO TOP